ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy

Giorgio Ciprandi, D. Fenoglio, F. Ferrera, M. De Amici, G. Marseglia

Research output: Contribution to journalArticlepeer-review

Abstract

Allergic rhinitis (AR) is characterized by a Th2 polarized immune response, and specific immunotherapy modifies this arrangement, restoring a physiologic Th1 profile. Sublingual immunotherapy (SLIT) is widely prescribed. The aim of the study is to evaluate two different methods for assessing IFN-γ, namely ELISPOT and ELISA, before and after a pre-seasonal SLIT course as marker for Th1 response. Thirty-eight AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. Patients' blood samples for assessing IFN-γ serum levels were collected before initiating SLIT (baseline - T0), after 3 months pre-seasonal SLIT course (T1), and three months after completion of SLIT (T2). IFN-γ-specific producing cells, after allergen stimulation, were assessed by cytokine ELISPOT at the same time points. IFN-γ-specific producing cells significantly increased after SLIT both at T1 and T2 (p=0.0002). On the contrary, ELISA assessment did not reveal an increase in IFN-γ serum levels at any time point. In conclusion, these results demonstrate that ELISA assessment of serum IFN-γ is not suitable for identifying an early response.

Original languageEnglish
Pages (from-to)31-35
Number of pages5
JournalEuropean Journal of Inflammation
Volume8
Issue number1
Publication statusPublished - Jan 2010

Keywords

  • Allergen
  • Allergic rhinitis
  • ELISA
  • ELISPOT
  • IFN-γ
  • Pollens
  • Sublingual immunotherapy
  • Th1 cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy'. Together they form a unique fingerprint.

Cite this